State Street's 4.6% stake is a routine passive holding by a large index/asset manager. The filing shows a reduction from the 12.4% stake BlackRock reported in October 2026, suggesting institutional rotation. Monitor upcoming 13F filings for broader institutional positioning ahead of Phase 3 ECLIPSE 1 data expected in Q4 2026.
VIR drugs
VIR drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $13.15entry
- T+1 · 6d ago −0.15%α −1.47% · $13.13
- T+4 · todayOpen
- T+5 · in 6h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
State Street Corporation filed a Schedule 13G disclosing a 4.6% passive stake in Vir Biotechnology as of September 30, 2026, down from 12.4% reported by BlackRock in the prior 13G/A. This is a routine passive filing by a large asset manager with no activist intent.
Key Financial Metrics
Key Facts
- State Street Corp disclosed beneficial ownership of 7,822,781 shares of Vir Biotechnology common stock as of September 30, 2026
- The stake represents 4.6% of shares outstanding
- Filing certifies passive intent under Rule 13d-1(b) with no control intent
- State Street is a large asset manager (custodian bank) filing as a parent holding company
Financial Impact
State Street holds 7.8M shares, approximately 4.6% of Vir Biotechnology's outstanding stock; at a $2.1B market cap this stake is worth roughly $97M
Risk Factors
- No activist intent or control influence expected from this passive filing
- Stake is below the 5% threshold that would require a 13G, but was filed voluntarily or due to aggregate group holdings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000742 |
| Document: 0000093751-26-000742-index.html | 0000093751-26-000742 |
| Document: 0000093751-26-000742.txt | 0000093751-26-000742 |
Track record
36 reports on VIR
4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today 424B5 Bearish 5/10 Entry $9.84 Now $9.58 +2.64% settles Nov 23
- Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
- Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
- Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $13.15 Now $9.58 −27.15% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
- Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
- Nov 2, 202614d ago 144 Neutral 1/10 Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers